ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
48 announcements
KIMS reported strong Q1 FY27 results with consolidated operating revenue growth of 35.3% YoY and 9.8% QoQ, driven by expansion and higher occupancy in core clusters.
Krishna Institute of Medical Sciences Ltd reported revenue from operations of ₹1,180 Cr (+35.3% YoY) and net profit of ₹37.4 Cr (-56.0% YoY) for Q1 FY27.
Krishna Institute of Medical Sciences has scheduled a board meeting for August 03, 2026. The board will consider and approve unaudited financial results for the first quarter.
Krishna Institute of Medical Sciences Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The filing details the distribution of equity shares among various stakeholders.
KIMS issued a corrigendum to its EGM notice for a preferential issue. The correction addresses typographical errors and clarifications requested by NSE.
KIMS Hospitals issued a corrigendum to correct debt figures in its EGM notice for a preferential issue. The revised total debt is ₹342.79 Crore as of April 2026.
KIMS launched a QIP to raise funds from institutional investors at a floor price of ₹771.73 per share. The issue will strengthen the company's capital base for growth.
Krishna Institute of Medical Sciences filed its audited standalone and consolidated financial statements for FY2026. The statutory audit report is enclosed following board approval.
KIMS board approved a preferential issue of 77,02,182 warrants at ₹779 each to promoters, raising ₹600 Crore. The funds will strengthen the company's capital base for future growth.
KIMS board will meet on 13 June 2026 to evaluate a fund raising proposal. The trading window is closed until 48 hours after the meeting outcome.
Krishna Institute of Medical Sciences Limited filed its Annual Secretarial Compliance Report for FY 2025-26. The auditor reported no material non-compliances or fines.
KIMS Hospitals Q4 FY26 earnings call highlighting robust 35.3% revenue growth to INR 1,084cr, despite EBITDA margin contraction to 19.9% due to heavy expansion and new unit drags.
KIMS delivered FY26 revenue growth of 28.2% YoY, reaching ₹39,308 Mn. Expansion continues across Telangana, AP, Maharashtra, and Kerala with a vision to reach 8600+ beds.
KIMS Hospitals reported FY26 revenue of ₹3,931 Crore, marking 28.2% YoY growth. The company achieved strong operational metrics with ARPOB increasing by 14%.
KIMS Limited signed a 60-year lease for a new 500-bedded hospital in Amaravati. This expansion enhances its tertiary care presence in Andhra Pradesh.
Krishna Institute of Medical Sciences Limited has scheduled a board meeting on May 15, 2026, to approve audited standalone and consolidated financial results for the year ended March 31, 2026. The company also announced the closure of its trading window from April 1, 2026, until 48 hours after the results announcement.
Krishna Institute of Medical Sciences Limited (KIMS) entered into a strategic clinical collaboration with Dakshayani Healthcare Services (Renova). This non-commercial partnership focuses on sharing oncology expertise and protocols to enhance healthcare delivery standards and patient outcomes across India.
Krishna Institute of Medical Sciences Limited announced that shareholders approved a special resolution for raising funds through a Qualified Institutions Placement (QIP). The resolution passed with a requisite majority via postal ballot on April 15, 2026. This approval enables the company to issue equity shares to investors for capital raising.